SCHEMBL7749688

SCHEMBL7749688

CCC(=O)N(C(=O)NC(C)[C]=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.41
ALDH1A1 P00352 4/20 0.41
TP53 P04637 2/20 0.41
LMNA P02545 1/20 0.41
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
GLA P06280 1/20 0.36
TSHR P16473 1/20 0.36
OPRM1 P35372 2/20 0.35
APAF1 O14727 1/20 0.35
NPC1 O15118 1/20 0.35
CASP3 P42574 1/20 0.35
HTT P42858 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
MAPT P10636 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPK1 P28482 1/20 0.34
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7749691 1.00 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1TP53LMNAMEN1
SCHEMBL11052611 0.85 PTGES (0.43) SMN1; SMN2ALDH1A1TP53LMNAMEN1
SCHEMBL7748067 0.78 KMT2A (0.40) SMN1; SMN2ALDH1A1TP53LMNAMEN1
SCHEMBL11683956 0.77 NAALAD2 (0.42) SMN1; SMN2ALDH1A1LMNAMEN1KMT2A
SCHEMBL7747129 0.76 ALDH1A1 (0.38) SMN1; SMN2ALDH1A1TP53LMNAMEN1
SCHEMBL7747126 0.76 ALDH1A1 (0.38) SMN1; SMN2ALDH1A1TP53LMNAMEN1
SCHEMBL8619637 0.76 ALDH1A1 (0.52) SMN1; SMN2ALDH1A1TP53LMNAMEN1
SCHEMBL7748040 0.75 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1TP53LMNAMAPT
SCHEMBL7750089 0.74 DPP4 (0.38) SMN1; SMN2ALDH1A1MEN1KMT2ANPC1
SCHEMBL7750080 0.74 DPP4 (0.38) SMN1; SMN2ALDH1A1MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0622361-B1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO (JP) 2001-10-04 EP disclosed
US-6169095-B1 FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES IN THE EYE, SUCH AS ALLERGY, INFLAMMATION AND PAIN OF THE EYE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
US-5922711-A ANTIALLERGENS, ANTIINFLAMMATORY AGENTS, AUTOIMMUNE DISEASES, SHOCK OR ANALGESICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-07-13 US disclosed
EP-0596406-B1 Imidazo (1,2-a) Pyridines as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO (JP) 1998-12-16 EP disclosed
US-5750699-A HALOGENATING OF CORRESPONDING COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-12 US disclosed
US-5708173-A PREPARATION OF SUBSTITUTED QUINOLINE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-13 US disclosed
US-5574042-A ANTAGONIST FOR BRADYKININS AS ANTIALLERGENS, AUTOIMMUNE DISEASES, ANTIINFLAMMATORY AGENTS, SHOCK OR PAIN FUJISAWA PHARMACEUTICAL CO., LTD (JP) 1996-11-12 US disclosed
US-5563162-A CAN BE ADMINISTERD FOR THE TREATMENT OF ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASES, SHOCK OR PAIN IN ANIMALS AND HUMANS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-08 US disclosed
EP-0596406-A1 Imidazo (1,2-a) Pyridines as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-05-11 EP disclosed